China drugmakers axe IPO plans as they face scrutiny in anti-graft drive
By Jason Xue and Tom Westbrook SHANGHAI (Reuters) – A growing number of healthcare companies in China are shelving their initial public offering (IPO) plans as its stock exchanges have stepped up…
Russia says medicine production stable as drugmakers pull out -RIA
– Russian Health Minister Mikhail Murashko on Thursday said the situation with medicines was stable in Russia and that all producers were continuing to work, the RIA news agency reported. Britain’s GlaxoSmithKline…
U.S. should review drugmakers’ opioid settlement tax breaks – House panel
WASHINGTON – The U.S. Justice and Treasury Departments should review the tax deductions four drugmakers made related to their $26 billion opioid settlement, the U.S. House Oversight and Reform Committee said in…
Breaking News
